ImmuCell Corporation (ICCC) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immucell Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.246 -- 00:00:05.672 Good morning, everyone, and welcome to the EmuCell Corporation conference call to discuss 00:00:05.672 -- 00:00:11.320 strategic change in focus and unaudited 2025 sales results. 00:00:11.320 -- 00:00:14.224 All participants will be in a listen-only mode. 00:00:14.224 -- 00:00:18.170 After today's presentation, there will be an opportunity to ask questions. 00:00:18.170 -- 00:00:20.092 Please also note today's event is being recorded. 00:00:20.092 -- 00:00:25.881 At this time, I'd like to turn the floor over to Joe Diaz with Lithium Partners. 00:00:25.881 -- 00:00:27.363 Please go ahead. 00:00:27.363 -- 00:00:30.794 Thank you, Jamie. Good morning and welcome. 00:00:30.794 -- 00:00:35.718 As our operator indicated, my name is Joe Diaz with Lithum Partners. 00:00:35.718 -- 00:00:39.442 We're the investor relations consulting firm for Emucel. 00:00:39.442 -- 00:00:45.207 I thank all of you for joining us today to discuss a change in Emucel strategic focus 00:00:45.207 -- 00:00:52.171 and the unaudited sales results for the fourth quarter and full year, December 31, 2025. 00:00:52.954 -- 00:00:57.237 Listeners are reminded and cautioned that statements made by management during the course 00:00:57.237 -- 00:01:00.359 of this call include forward-looking statements. 00:01:00.359 -- 00:01:05.804 which include any statement that refers to future events or expected future results 00:01:05.804 -- 00:01:10.049 or predictions about steps the company plans to take in the future. 00:01:10.049 -- 00:01:14.934 These statements are not guarantees of performance and are subject to risks and uncertainties 00:01:14.934 -- 00:01:19.979 that could cause actual results, outcomes, or events to differ materially 00:01:19.979 -- 00:01:23.342 from those dis...